Your browser doesn't support javascript.
loading
Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population.
Funch, Donnie; Mortimer, Kathleen; Ziyadeh, Najat J; Seeger, John D; Li, Ling; Norman, Heather; Major-Pedersen, Atheline; Bosch-Traberg, Heidrun; Gydesen, Helge; Dore, David D.
  • Funch D; Optum Epidemiology, Boston, Massachusetts.
  • Mortimer K; Optum Epidemiology, Boston, Massachusetts.
  • Ziyadeh NJ; Optum Epidemiology, Boston, Massachusetts.
  • Seeger JD; Optum Epidemiology, Boston, Massachusetts.
  • Li L; Optum Epidemiology, Boston, Massachusetts.
  • Norman H; Optum Epidemiology, Boston, Massachusetts.
  • Major-Pedersen A; Global Safety, Novo Nordisk A/S, Copenhagen, Denmark.
  • Bosch-Traberg H; Global Development, Novo Nordisk A/S, Copenhagen, Denmark.
  • Gydesen H; Epidemiology, Novo Nordisk A/S, Copenhagen, Denmark.
  • Dore DD; Optum Epidemiology, Boston, Massachusetts.
Diabetes Obes Metab ; 21(8): 1837-1848, 2019 08.
Article en En | MEDLINE | ID: mdl-30945402

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pancreatitis / Incretinas / Liraglutida / Hipoglucemiantes / Seguro de Salud Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: America do norte Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pancreatitis / Incretinas / Liraglutida / Hipoglucemiantes / Seguro de Salud Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: America do norte Idioma: En Año: 2019 Tipo del documento: Article